1 Min Read
Oct 16 (Reuters) - BERGENBIO ASA:
* PRESENTATIONS ON PHASE 2 CLINICAL TRIALS WITH BGB324 IN LUNG CANCER PATIENTS AT WORLD CONFERENCE IN JAPAN Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.